Sign in

NCT07217444Recruiting

Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation

Source: ClinicalTrials.gov · Last updated 11 Feb 2026

Brief summary (registry, in English)

Evaluate the feasibility, safety, and preliminary efficacy of deep Transcranial Magnetic Stimulation (dTMS) as an adjunctive treatment for adolescents hospitalized with major depressive disorder (MDD).

Status (registry)
Recruiting
Study type
Interventional
Enrollment
60 (estimated)
First submitted
8 Oct 2025
Start date
13 Nov 2025
Primary completion date
30 Dec 2026
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Diseases
Depression
NCT number
NCT07217444

What you commit to

  • Study type: Interventional
  • Planned participants: 60
  • From 13 Nov 2025 to the primary completion date, 30 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in an investigational drug trial within the past three months.

Other illness

  • Contraindications to Transcranial Magnetic Stimulation including, but not limited to, a history of epilepsy, the presence of metallic foreign bodies, or implanted medical devices (e.g. ventriculoperitoneal shunt, pacemaker, medical pump).

Other

  • Actively psychotic (i.e. disorganized, delusional, paranoid, or having hallucinations)
  • Actively suicidal (have a suicidal plan and intent and is on 1:1 close observation)
  • For female subjects of childbearing potential, a positive urine pregnancy test.

Who the study is looking for

  • Fluent in English and able to volunteer in the informed consent process and provide spontaneous narrative description of key elements, risks, and benefits of the study.
  • Aged 14 years to 18 years, inclusive.
  • Diagnosis of MDD based on psychologist diagnosis and DSM-5-checklist based interview.
  • Symptoms of moderate to severe depression according to Hamilton Depression Rating Scale Score \> 20.
  • Participants are not required to discontinue current interventions

Age in the registry: 14 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cincinnati Childrens Hospital Medical Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.